Condition
Mycobacterium Avium Complex Pulmonary Disease clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Mycobacterium Avium Complex Pulmonary Disease clinical trials that are recruiting, at sites in 11 countries (most in China (3), Belgium (1), Canada (1)). By phase: Phase 4 (3). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 11Countries
Newest Mycobacterium Avium Complex Pulmonary Disease clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Shortened contezolid-enhanced treatment for Mycobacterium avium complex lung disease | Phase 4 | Hefei, Anhui and 5 other locations | Recruiting | Oct 9, 2025 |
| Preventing MAC lung disease from coming back with Cordyceps sinensis capsules | Phase 4 | Hefei, Anhui and 5 other locations | Recruiting | Sep 15, 2025 |
| Short-term bactericidal effect of contezolid for Mycobacterium avium complex lung disease | Phase 4 | Beijing, Beijing Municipality and 2 other locations | Recruiting | Jul 24, 2025 |
| Observational study on treatment effectiveness for Mycobacterium Avium Complex Pulmonary Disease | — | Portland, Oregon and 10 other locations | Recruiting | Jun 15, 2023 |
All recruiting trials (4)
-
Shortened contezolid-enhanced treatment for Mycobacterium avium complex lung disease
This study will try adding contezolid to standard antibiotics to see if adults with Mycobacterium avium complex lung disease can have lower bacterial counts, less lung damage, and better quality of life with a 6-month treatment.
-
Preventing MAC lung disease from coming back with Cordyceps sinensis capsules
This trial will test whether taking a daily Cordyceps sinensis (Bailiing) capsule for 12 months can prevent recurrence of Mycobacterium avium complex (MAC) lung disease in adults who have been microbiologically cured.
-
Short-term bactericidal effect of contezolid for Mycobacterium avium complex lung disease
This trial tests whether giving adults with MAC pulmonary disease contezolid in addition to the usual antibiotics helps reduce bacteria in sputum and checks for safety.
-
Observational study on treatment effectiveness for Mycobacterium Avium Complex Pulmonary Disease
This study is trying to see how well a three-drug treatment works for people newly diagnosed with Mycobacterium avium complex pulmonary disease and how well they stick to the treatment plan.
Quick answers
How many Mycobacterium Avium Complex Pulmonary Disease clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 11 countries. The most sites are in China (3 trials), Belgium (1 trial), Canada (1 trial), Croatia (1 trial), Denmark (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 3. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.